ACTIVE

NEWPHARMA

Export PDF

Financial year 2025 · closed on 31/03/2025

Net result

273,3 k €

+195.8% YoY

Revenue

201,8 M €

-10.8% YoY

Equity

2,5 M €

+12.2% YoY

Workforce

14,6 ETP

-0.7% YoY

What does NEWPHARMA do?

NEWPHARMA is a Public limited company incorporated in 2011. Its main activity is: Retail sale in non-specialised stores. Its registered office is in Liège. It employs on average 14,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0838.666.156

Incorporation

22/08/2011

Legal form

Public limited company

Registered office

Rue Basse-Wez 315/317
4020 Liège · WallonieSee on map

Contributed capital

5 050 000,00 €

Latest accounts

31/03/2025

Average workforce

14,6 ETP

Activities (NACE)

47120Retail sale in non-specialised stores· main 47910Retail sale via mail order houses or via Internet 47730Dispensing chemist in specialised stores 47730Dispensing chemist in specialised stores

Joint committees (1)

Signals

ProfitablePositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 14 financial years

	2025		2024		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011
Income statement
Revenue	201,8 M €	-10.8%	226,2 M €	+38.9%	162,8 M €	+5.7%	154 M €	+6.1%	145,1 M €	+52.2%	95,3 M €	+16.6%	81,8 M €	+29.1%	63,4 M €		–		–		–		–		8,7 M €	+59584%	14,6 k €
EBITDA	180,2 k €	+116%	-1,1 M €	+31.2%	-1,6 M €	-157%	-631,7 k €	-2508%	26,2 k €	-93.3%	392 k €	-70.1%	1,3 M €	-31.4%	1,9 M €	+4.9%	1,8 M €	+17.6%	1,5 M €	+71.1%	905,8 k €	+73.0%	523,5 k €	+21.9%	429,3 k €	+849%	-57,3 k €
Operating result	123,9 k €	+127%	-461 k €	+67.1%	-1,4 M €	-289%	741 k €	+231%	-567,1 k €	-261%	352,8 k €	-71.8%	1,2 M €	-32.5%	1,9 M €	+5.2%	1,8 M €	+17.6%	1,5 M €	+74.8%	855,3 k €	+74.8%	489,4 k €	+23.2%	397,2 k €	+727%	-63,4 k €
Net result	273,3 k €	+196%	-285,2 k €	+79.4%	-1,4 M €	-408%	-273,4 k €	+84.8%	-1,8 M €	-261%	-497,6 k €	-272%	289,6 k €	-65.2%	832,3 k €	-0.4%	836 k €	+19.1%	701,8 k €	+83.9%	381,6 k €	+99.7%	191,1 k €	+1.4%	188,4 k €	+383%	-66,6 k €
Balance sheet
Equity	2,5 M €	+12.2%	2,2 M €	-11.3%	2,5 M €	+333%	-1,1 M €	-33.8%	-810 k €	-182%	986,7 k €	-33.5%	1,5 M €	+24.2%	1,2 M €	+230%	362,3 k €	+0.0%	362,3 k €	-0.1%	362,5 k €	-0.1%	362,9 k €	+111%	171,8 k €	+1134%	-16,6 k €
Total assets	27,4 M €	-9.6%	30,3 M €	+15.3%	26,3 M €	+18.0%	22,3 M €	-7.8%	24,2 M €	+62.1%	14,9 M €	+19.0%	12,5 M €	+44.7%	8,7 M €	+19.9%	7,2 M €	+69.4%	4,3 M €	+28.7%	3,3 M €	+17.1%	2,8 M €	+44.3%	2 M €	+390%	400,7 k €
Cash	5 M €	-29.8%	7,1 M €	+172%	2,6 M €	+67.3%	1,6 M €	-43.1%	2,7 M €	+89.4%	1,4 M €	-39.6%	2,4 M €	-8.1%	2,6 M €	+61.8%	1,6 M €	+47.2%	1,1 M €	+20.7%	905,5 k €	-41.4%	1,5 M €	+67.1%	925,4 k €	+2885%	31 k €
Debts	23,7 M €	-13.3%	27,3 M €	+19.9%	22,8 M €	+3.1%	22,1 M €	-1.7%	22,5 M €	+61.8%	13,9 M €	+26.2%	11 M €	+49.2%	7,4 M €	+7.5%	6,9 M €	+75.8%	3,9 M €	+32.3%	3 M €	+20.6%	2,4 M €	+36.7%	1,8 M €	+330%	415,7 k €
Other
Workforce	14,6 ETP	-0.7%	14,7 ETP	-4.5%	15,4 ETP	+2.7%	15,0 ETP	+28.2%	11,7 ETP	+31.5%	8,9 ETP	+30.9%	6,8 ETP	+65.9%	4,1 ETP	+57.7%	2,6 ETP	-27.8%	3,6 ETP	-7.7%	3,9 ETP	-17.0%	4,7 ETP	-27.7%	6,5 ETP	+3150%	0,2 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/03/2025 · 5 active · 6 ended

Active mandates

GJ LIFESCIENCES MANAGEMENT

Director · since 14 juillet 2021 · until 25 juin 2027 · 0770.962.631

Represented by GILLES JOURQUIN

Active

JO WILLEMUNS

Mandate

Active

KRIS CASTELEIN

Mandate

Active

STEFAAN VANDAMME

Mandate

Active

STEFAN GOETHAERT

Mandate

Active

Ended mandates

JGO

Manager · since 17 décembre 2017 · until 25 mai 2023 · 0643.915.001

Represented by JEROME GOBBESSO

Ended

JGO

Director · since 17 décembre 2017 · until 25 mai 2023 · 0643.915.001

Represented by JEROME GOBBESSO

Ended

DEEP DIVE

Manager · 0895.939.411

Represented by JEROME GOBBESSO

Ended

JEROME GOBBESSO

Manager

Ended

Annual accounts

Full financial information

	2025	2024	2022	2021	2020	2019
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/04/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/03/2025	31/03/2024	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	15 months	12 months	12 months	12 months	12 months
Filing date	25/09/2025	19/09/2024	05/07/2023	06/07/2022	28/07/2021	14/08/2020
General meeting	16/09/2025	17/09/2024	30/06/2023	30/06/2022	30/06/2021	30/07/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

14 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/03/2025	16/09/2025	25/09/2025	French	PDF
Full model	31/03/2024	17/09/2024	19/09/2024	French	PDF
Full model	31/12/2022	30/06/2023	05/07/2023	French	PDF
Full model	31/12/2021	30/06/2022	06/07/2022	French	PDF
Full model	31/12/2020	30/06/2021	28/07/2021	French	PDF
Full model	31/12/2019	30/07/2020	14/08/2020	French	PDF
Full model	31/12/2018	28/06/2019	25/07/2019	French	PDF
Full model	31/12/2017	21/06/2018	10/07/2018	French	PDF
Abridged model	31/12/2016	30/06/2017	25/07/2017	French	PDF
Abridged model	31/12/2015	21/09/2016	28/09/2016	French	PDF
Abridged model	31/12/2014	31/07/2015	19/08/2015	French	PDF
Abridged model	31/12/2013	04/06/2014	20/06/2014	French	PDF
Abridged model	31/12/2012	30/06/2013	19/07/2013	French	PDF
Abridged model	31/12/2011	30/06/2012	14/07/2012	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2025 · 5 active · 6 ended

Active mandates

GJ LIFESCIENCES MANAGEMENT

Director · since 14 juillet 2021 · until 25 juin 2027 · 0770.962.631

Represented by GILLES JOURQUIN

Active

JO WILLEMUNS

Mandate

Active

KRIS CASTELEIN

Mandate

Active

STEFAAN VANDAMME

Mandate

Active

STEFAN GOETHAERT

Mandate

Active

Ended mandates

JGO

Manager · since 17 décembre 2017 · until 25 mai 2023 · 0643.915.001

Represented by JEROME GOBBESSO

Ended

JGO

Director · since 17 décembre 2017 · until 25 mai 2023 · 0643.915.001

Represented by JEROME GOBBESSO

Ended

DEEP DIVE

Manager · 0895.939.411

Represented by JEROME GOBBESSO

Ended

JEROME GOBBESSO

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Capital / shares21/11/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - CAPITAL, ACTIONS
PDF
Mandates17/01/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - ANNEE COMPTABLE
PDF
Mandates20/10/2023
DEMISSIONS, NOMINATIONS
PDF
Capital / shares09/01/2023
MODIFICATION FORME JURIDIQUE - CAPITAL, ACTIONS
PDF
Mandates28/09/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates26/02/2021
DEMISSIONS, NOMINATIONS - MODIFICATION FORME JURIDIQUE
PDF
Mandates06/07/2018
DEMISSIONS, NOMINATIONS
PDF
Mandates09/01/2018
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025273,3 k €↑
2024
Annual accounts 2024-285,2 k €↑
2022
Annual accounts 2022-1,4 M €↓
2021
Annual accounts 2021-273,4 k €↑
2020
Annual accounts 2020-1,8 M €↓
2019
Annual accounts 2019-497,6 k €↓
2018
Annual accounts 2018289,6 k €↓
2017
Annual accounts 2017832,3 k €↓
2016
Annual accounts 2016836 k €↑
2015
Annual accounts 2015701,8 k €↑
2014
Annual accounts 2014381,6 k €↑
2013
Annual accounts 2013191,1 k €↑
2012
Annual accounts 2012188,4 k €↑
2011
Annual accounts 2011-66,6 k €
22/08/2011
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

NEWPHARMA

Overview

What does NEWPHARMA do?

Trend over 14 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline